e-Drug3D 472 |
NADOLOL
|
cas 42200-33-9 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
PK parameters VD 123.5 LITER (65 KILOGRAM) Solubility SLIGHTLY SOLUBLE IN WATER |
Target TARGET BETA-1 ADRENERGIC RECEPTOR |
DrugCentral Beta-1 adrenergic receptor UNIPROT P08588 ADRB1 Beta-2 adrenergic receptor UNIPROT P07550 ADRB2 |
Download SDF file | (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol Formula: Calculated chemical properties: MW 309.40 NB_atoms 22 XLogP 0.63 PSA 85.588 NB_HD 4 NB_HA 5 fsp3 0.65 Lipinski(0=no;1=yes) 1 |
FDA NDA 018063 (pdf not found) INN (NADOLOL) CORGARD (USWM) APPROVAL= AP YEAR= 1979 DISCONTINUED NDA 018647 (pdf not found) INN (BENDROFLUMETHIAZIDE ; NADOLOL) CORZIDE (KING PHARMS LLC) APPROVAL= AP YEAR= 1983 DISCONTINUED NDA 074172 (pdf not found) INN (NADOLOL) NADOLOL (RISING) APPROVAL= AP YEAR= 1993 NDA 074368 (pdf not found) INN (NADOLOL) NADOLOL (TEVA PHARMS) APPROVAL= AP YEAR= 1994 DISCONTINUED NDA 074501 (pdf not found) INN (NADOLOL) NADOLOL (SANDOZ) APPROVAL= AP YEAR= 1995 NDA 074229 (pdf not found) INN (NADOLOL) NADOLOL (HERITAGE PHARMA) APPROVAL= AP YEAR= 1996 DISCONTINUED NDA 074255 (pdf not found) INN (NADOLOL) NADOLOL (HERITAGE PHARMA) APPROVAL= AP YEAR= 1996 DISCONTINUED NDA 077833 (pdf not found) INN (BENDROFLUMETHIAZIDE ; NADOLOL) NADOLOL AND BENDROFLUMETHIAZIDE (IMPAX LABS) APPROVAL= AP YEAR= 2007 DISCONTINUED NDA 078688 (pdf not found) INN (BENDROFLUMETHIAZIDE ; NADOLOL) NADOLOL AND BENDROFLUMETHIAZIDE (MYLAN) APPROVAL= AP YEAR= 2008 DISCONTINUED NDA 201893 (pdf not found) INN (NADOLOL) NADOLOL (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2015 NDA 203455 (pdf not found) INN (NADOLOL) NADOLOL (INVAGEN PHARMS) APPROVAL= AP YEAR= 2015 NDA 207761 (pdf not found) INN (NADOLOL) NADOLOL (ZYDUS PHARMS) APPROVAL= AP YEAR= 2017 NDA 208832 (pdf not found) INN (NADOLOL) NADOLOL (AMNEAL PHARMS CO) APPROVAL= AP YEAR= 2017 NDA 209309 (pdf not found) INN (NADOLOL) NADOLOL (CHARTWELL RX) APPROVAL= AP YEAR= 2017 NDA 210786 (pdf not found) INN (NADOLOL) NADOLOL (NOVAST LABS) APPROVAL= AP YEAR= 2018 DISCONTINUED NDA 210955 (pdf not found) INN (NADOLOL) NADOLOL (BEXIMCO PHARMS USA) APPROVAL= AP YEAR= 2018 NDA 212856 (pdf not found) INN (NADOLOL) NADOLOL (RK PHARMA) APPROVAL= AP YEAR= 2019 NDA 211763 (pdf not found) INN (NADOLOL) NADOLOL (ALEMBIC) APPROVAL= AP YEAR= 2023 |
Other links: |